|
DYRK1A expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.71360000423127E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.31249999999417E-05 |
| Normal-vs-Stage2 |
1.001120E-03 |
| Normal-vs-Stage3 |
9.35720000039275E-07 |
| Normal-vs-Stage4 |
4.60730009699262E-10 |
| Stage1-vs-Stage2 |
4.795000E-01 |
| Stage1-vs-Stage3 |
5.512400E-02 |
| Stage1-vs-Stage4 |
5.412500E-04 |
| Stage2-vs-Stage3 |
5.161000E-01 |
| Stage2-vs-Stage4 |
5.100200E-02 |
| Stage3-vs-Stage4 |
1.044380E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.53319999818669E-08 |
| Normal-vs-AfricanAmerican |
4.214600E-04 |
| Normal-vs-Asian |
9.862800E-01 |
| Caucasian-vs-AfricanAmerican |
9.185400E-01 |
| Caucasian-vs-Asian |
9.685700E-02 |
| AfricanAmerican-vs-Asian |
1.450010E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.19419999947235E-08 |
| Normal-vs-Female |
4.30869999999972E-05 |
| Male-vs-Female |
1.152390E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.210900E-04 |
| Normal-vs-Age(41-60Yrs) |
2.36439999999893E-05 |
| Normal-vs-Age(61-80Yrs) |
1.09080000032513E-07 |
| Normal-vs-Age(81-100Yrs) |
1.824600E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.448400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.580000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.592600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.135600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.024000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.489600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.186600E-01 |
| Normal-vs-Grade 2 |
2.362000E-04 |
| Normal-vs-Grade 3 |
6.50310000294141E-08 |
| Normal-vs-Grade 4 |
2.85440004965665E-10 |
| Grade 1-vs-Grade 2 |
4.551600E-02 |
| Grade 1-vs-Grade 3 |
2.482900E-03 |
| Grade 1-vs-Grade 4 |
8.17880000000271E-05 |
| Grade 2-vs-Grade 3 |
8.518300E-03 |
| Grade 2-vs-Grade 4 |
2.177500E-04 |
| Grade 3-vs-Grade 4 |
6.313900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.137870E-03 |
| Normal-vs-ccB subtype |
1.32360000004716E-06 |
| ccA subtype-vs-ccB subtype |
2.693600E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.81440000005073E-06 |
| Normal-vs-N1 |
7.57930000000462E-05 |
| N0-vs-N1 |
1.165990E-01 |
|
|
